Next Article in Journal
Local Immune Biomarker Expression Depending on the Uterine Microbiota in Patients with Idiopathic Infertility
Next Article in Special Issue
Natural Products as the Potential to Improve Alzheimer’s and Parkinson’s Disease
Previous Article in Journal
SELENOP rs3877899 Variant Affects the Risk of Developing Advanced Stages of Retinopathy of Prematurity (ROP)
Previous Article in Special Issue
Magnoflorine from Berberis vulgaris Roots—Impact on Hippocampal Neurons in Mice after Short-Term Exposure
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 8
10.3390/ijms24087569
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Linderone Isolated from Lindera erythrocarpa Exerts Antioxidant and Anti-Neuroinflammatory Effects via NF-κB and Nrf2 Pathways in BV2 and HT22 Cells

by
Zhiming Liu
1,
Chi-Su Yoon
2,3,
Hwan Lee
1,
Hyeong-Kyu Lee
3 and
Dong-Sung Lee
1,*
1
College of Pharmacy, Chosun University, Dong-gu, Gwangju 61452, Republic of Korea
2
Natural Medicine Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB), Cheongju-si 28116, Republic of Korea
3
Department of Chemistry, University of Florida, Gainesville, FL 32611, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(8), 7569; https://doi.org/10.3390/ijms24087569
Submission received: 22 March 2023 / Revised: 15 April 2023 / Accepted: 18 April 2023 / Published: 20 April 2023
(This article belongs to the Special Issue New Pharmacological Insights on Natural Macromolecules and Natural Small Molecules)
Browse Figures
Versions Notes

Abstract

:
Linderone is a major compound in Lindera erythrocarpa and exhibits anti-inflammatory effects in BV2 cells. This study investigated the neuroprotective effects and mechanisms of linderone action in BV2 and HT22 cells. Linderone suppressed lipopolysaccharide (LPS)-induced inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines (e.g., tumor necrosis factor alpha, interleukin-6, and prostaglandin E-2) in BV2 cells. Linderone treatment also inhibited the LPS-induced activation of p65 nuclear factor-kappa B, protecting against oxidative stress in glutamate-stimulated HT22 cells. Furthermore, linderone activated the translocation of nuclear factor E2-related factor 2 and induces the expression of heme oxygenase-1. These findings provided a mechanistic explanation of the antioxidant and anti-neuroinflammatory effects of linderone. In conclusion, our study demonstrated the therapeutic potential of linderone in neuronal diseases.

1. Introduction

Neurodegenerative diseases, such as Parkinson’s disease and Alzheimer’s disease, are often associated with neuroinflammation. As an important immune response, neuroinflammation protects the body from damage by eliminating harmful factors and repairing cells and tissues. However, excessive neuroinflammation can lead to severe neurological dysfunction [1,2,3]. Microglia are key immune cells that mediate inflammation in the central nervous system [4,5,6]. Under the stimulation of lipopolysaccharide (LPS), microglia produce prostaglandin E2 (PGE2) and nitric oxide (NO) through the expression of proinflammatory proteins, inducible nitric oxide synthase (iNOS), and cyclooxygenase (COX-2), resulting in inflammatory-related neurological dysfunction [7,8,9]. In addition, nuclear factor κB (NF-κB) signal transduction is crucial in the process of microglia-mediated neuroinflammation. Nuclear factor-κB (NF-κB)/Rel proteins include NF-κB2 p52/p100, NF-κB1 p50/p105, c-Rel, RelA/p65, and RelB. These proteins act as dimerization transcription factors, among which RelA/p65 is an important type of NF-κB/Rel protein and a key target for regulating inflammatory responses in cells [10]. Under unstimulated conditions, NF-κB is a complex composed of p65 and I-κB subunits, and exists in the cytoplasm [11]. However, LPS induction will lead to the phosphorylation of I-κB, leading to a structural change of the p65/I- κB complex, and the p65 subunit will be dissociated and transferred into the nucleus to affect the transcription of inflammatory factors [12]. After that, the free p65 subunit is transported to the nucleus, where it induces inflammatory factors such as tumor necrosis factor (TNF)-α and interleukin (IL)-6. Therefore, one strategy for inhibiting microglial inflammation is to regulate NF-κB translocation [13,14,15].
Another important pathogenesis of neurodegenerative diseases is oxidative stress [16,17,18]. Oxidative imbalances lead to imbalances in the antioxidant system, leading to the production of reactive oxygen species (ROS) [19]. Rising levels of reactive oxygen species can lead to cell apoptosis, damage proteins and organelles, damage mitochondrial membranes, and lead to neuronal cell death [20]. As a key regulator of the antioxidant response, nuclear factor E2 related factor 2 (Nrf2) can promote the expression of antioxidant enzymes, including heme oxygenase (HO)-1 [21]. HO-1 has strong antioxidant and anti-inflammatory effects [22]. In addition, the activation of the Nrf2/HO-1 pathway can reduce the NF-κB-mediated inflammatory response to prevent neuronal cell death. Therefore, the Nrf2/HO-1 pathway has been a therapeutic target for neuroprotective medicine [23,24].
Lindera erythrocarpa (family Lauraceae) is widely distributed in Korea, Japan, and China [25]. Our previous study identified the fungal metabolite linderone in L. erythrocarpa and found that it inhibited NO overproduction in lipopolysaccharide (LPS)-treated BV2 cells [26]. However, little research has been conducted on the neuroprotective effects of linderone.
In this study, we therefore investigated the anti-neuroinflammatory effects of linderone in LPS-stimulated BV2 cells. We also examined the protective effects of linderone in glutamate-induced HT22 cells.

2. Results

2.1. Effects of Linderone on BV2 and HT22 Cell Viability

Linderone was isolated from the leaves of L. erythrocarpa Makino (see Figure 1A for chemical structure). To determine the cytotoxic effects of linderone, we treated HT22 and BV2 cells with various linderone concentrations, followed by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The results showed that 10–40 μM was a safe concentration range (Figure 1B,C). Thus, we set the maximum treatment concentration of linderone at 40 μM for subsequent experiments.

2.2. Effects of Linderone on Inflammatory Factors in BV2 Cells

An LPS-induced BV2 cell was established for measuring nitrite production. We used sulfuretin (20 μM) as a positive control because its anti-inflammatory effect is excellent. The effect of linderone on nitrite levels was significant at 40 μM (Figure 2A). We demonstrated that prostaglandin E2 (PGE2) production was inhibited by linderone (Figure 2B). Linderone also inhibited IL-6 and TNF-α production (Figure 2C,D). Thus, linderone significantly reduced the level of inflammatory factors in LPS-induced BV2 cells.
Furthermore, western blots of inflammation-related protein expression showed that both iNOS and COX2 expression rose in LPS-treated cells, and linderone pretreatment inhibited this LPS-induced increase (Figure 3).

2.3. Effects of Linderone on Regulation of NF-κB (p65) Pathway in BV2 Cells

The cytosolic and nuclear fractions from LPS-induced BV2 cells were extracted to explore the inhibitory effect of linderone on the NF-κB pathway. We then measured the protein levels with western blotting. Linderone inhibited p-IκBα expression and p65 nuclear translocation (Figure 4A,B). Using immunofluorescence, we also compared p65 NF-κB expression in LPS-treated cells with and without the linderone treatment (Figure 4C). Linderone reduced the LPS-induced increase in p65 nuclear translocation. These results suggest that linderone blocks the LPS-induced production of neuroinflammatory cytokines through inhibiting the NF-κB pathway.

2.4. Effects of Linderone on Glutamate-Induced Oxidative Stress in HT22 Cells

Linderone was treated for proving neuroprotective effects against oxidative stress-induced cytotoxicity in glutamate-treated HT22 cells. Linderone exerted neuroprotective effects in glutamate-treated HT22 cells in a concentration-dependent manner (Figure 5A). Furthermore, the glutamate treatment group produced significantly more ROS than the control group (Figure 5B). Linderone, on the other hand, significantly reduced ROS production (Figure 5C).

2.5. Effects of Linderone on Nrf2/HO-1 Pathway in HT22 and BV2 Cells

To determine whether HO-1 was the source of linderone’s antioxidant effect, we treated BV2 and HT22 cells with various linderone concentrations for 12 h before performing western blotting. Cobalt protoporphyrin (CoPP) served as a positive control. Linderone significantly increased HO-1 expression in BV2 and HT22 cells (Figure 6).
We also explore the effect of linderone on Nrf2 activation. We measured Nrf2 expression every 0.5 h and observed that cytosolic Nrf2 transfers to the nucleus in BV2 and HT22 cells after linderone administration (Figure 7).
Tin protoporphyrin-IX (SnPP), a selective HO-1 inhibitor, was used to further examine whether the neuroprotective effects of linderone were related to the Nrf2/HO-1 pathway. Nitrite concentration was lower in the linderone group compared to those treated with both linderone and SnPP (Figure 8A). The neuroprotective effects were also stronger in the linderone-treated HT22 cells compared to those treated with both linderone and SnPP (Figure 8B). Additionally, SnPP treatment reversed the anti-inflammatory and neuroprotective effects of linderone, suggesting that HO-1 expression regulates linderone’s effects.

3. Discussion

Long used as a herbal medicine, L. erythrocarpa has been found to exhibit antioxidant, anti-inflammatory, anticancer, and antifungal activities. One of the main compounds in L. erythrocarpa is linderone, a cyclopentadione that shows anti-inflammatory effects on BV2 cells. Linderone is a compound belonging to the cyclopentadione class. Reports have shown that linderone not only has the ability to scavenge free radicals such as DPPH or ABTS [27], but can also inhibit NO production in RAW264.7 [28]. However, there are no papers about the regulation of neuronal effects using linderone. Here, we verified that this characteristic of linderone confers neuroprotection.
First, the cell viability experiment determined the safe concentration range of linderone (Figure 1). Next, the effects of linderone on neuroinflammation were confirmed in LPS-induced BV2 cells. Our results show that linderone can significantly inhibit the production of nitrite and PGE2 (Figure 2A,B). Nitrite and PGE2 are important inflammatory mediators produced by microglia. Nitrite is mediated by iNOS and then destroys the cell membrane of neurons, damaging DNA transcription and protein synthesis [28]. PGE2 is a COX-2 product that also plays an important role in neuroinflammation [29]. Other proinflammatory cytokines activated by NF-κB, including TNF- α and IL-6, were also significantly inhibited by linderone (Figure 2C,D). In the meantime, a western blot analysis showed that linderone also inhibited LPS-induced iNOS and COX-2 expression (Figure 3). NF-κB is a key regulatory protein of the aforementioned inflammatory factors, so the effect of linderone on the NF-κB pathway was also determined. As a key protein in the response of microglia to stimulation under ischemic, traumatic, neurotoxic, or inflammatory conditions [30], NF-κB activation contributes to neuronal damage and promotes the development of neurodegenerative diseases [31,32,33]. The results suggest that linderone significantly inhibited the nuclear translocation of p65 (Figure 4). In summary, these results demonstrate that linderone can inhibit inflammation via the NF-κB pathway in LPS-stimulated BV2 cells.
Neuronal apoptosis in neurodegenerative diseases is a direct cause of morbidity, and high concentrations of glutamate can induce neuronal apoptosis through oxidative stress [34]. Therefore, we studied the neuroprotective effect of linderone on glutamate-induced HT22 cells. The results show that linderone significantly improved glutamate-induced damage in HT22 cells and increased cell survival (Figure 5A). After that, our study measured ROS in HT22 cells using a fluorescence microscope. In glutamate-induced neuronal cells, the activation of ionic glutamate receptors leads to excessive ROS formation, ultimately leading to cell death [35]. The results show that Lindelun reversed the ROS produced by HT22 cells induced by glutamate (Figure 5B,C). This result indicates that ninhydrin can protect HT22 cells by inhibiting oxidative stress. The Nrf-2/HO-1 pathway is crucial in neuroprotective strategies [36]. The activation of HO-1 can protect neurons from oxidative damage [37]. Our results indicate that indenone induces HO-1 expression in both BV2 and HT22 cells (Figure 6A,B). On the other hand, Nrf2 is a negative regulator of HO-1, and after activation, it enters the nucleus for transcription and induces the production of HO-1 [38]. We found that linderone treatment decreased the content of Nrf2 in the cytoplasm, while increasing the content of Nrf2 in the nucleus (Figure 7). This result indicates that linderone can activate the Nrf2/HO-1 pathway in BV2 and HT22 cells. We also used SnPP, the inhibitor of HO-1, to verify this point. As expected, linderone reduced the nitrite levels in BV2 cells and protected HT22 cells from death, while SnPP reversed these beneficial effects (Figure 8). Therefore, it can be concluded that linderone significantly targets Nrf2/HO-1 to exert protective effects on HT22 cells. In this study, we only focused on the mechanism of cell protective effects or anti-neuroinflammation by linderone using the two cell lines, BV2 and HT22 cells; however, the neuroprotective effects in vivo should be further studied.

4. Materials and Methods

4.1. Materials

Cell reagents were purchased from Gibco BRL Co., Ltd. (Grand Island, NY, USA). Primary antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA); ELISA kits were purchased from R&D Systems Inc., (Minneapolis, MN, USA). Secondary antibodies were purchased from Millipore (Billerica MA, USA). Other reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).

4.2. Cell Culture and Cell Viability Assays

BV2 cells were incubated in RPMI1640 containing 1% penicillin-streptomycin and 10% FBS. HT22 cells were cultured in DMEM containing 10% FBS and 1% penicillin-streptomycin, under a humidified atmosphere of 5% CO2 and a temperature of 37 °C. Cell viability was measured with the MTT assay.

4.3. Measurement of NO Generation

Equal volumes of cell supernatant and Griess reagent were mixed for nitrite level determination.

4.4. PGE2 Assay

The culture supernatant was collected to determine the PGE2 levels per sample using a commercially available kit.

4.5. Assays for IL-6 and TNF-α

The supernatant of the BV2-cultured medium was collected to determine IL-6 and TNF-α levels using the ELISA method.

4.6. Western Blotting Analysis

Cells were lysed using a RIPA buffer. Protein was mixed with the sample loading buffer, then transferred onto nitrocellulose membranes, which were incubated in skimmed milk in order to block non-specific protein binding. Primary antibodies were treated at 4 °C overnight.

4.7. p65 Localization

BV2 cells were seeded on Lab-Tek II chamber slides and then treated with linderone or LPS. Formalin was used for fixing cells. Next, the p65 antibody and Alexa Fluor 488 were treated. DAPI was used to visualize nucleifor. Finally, cells were observed and photographed using a fluorescence microscope (Provis AX70; Olympus Optical Co., Tokyo, Japan).

4.8. Determination of ROS Levels in HT22 Cells

HT22 cells were incubated with DCFH-DA (10 μM) for 20 min. After PBS washing, cells were observed and photographed under a fluorescence microscope (Provis AX70; Olympus Optical Co., Tokyo, Japan).

4.9. Statistical Analysis

Data are shown as the average and standard deviation of three independent experiments. A one-way ANOVA method was adopted to analyze data using GraphPad Prism version 5.01 (GraphPad Software Inc., San Diego, CA, USA).

5. Conclusions

In conclusion, this study suggests linderone can suppress the activation of the NF-κB pathway in BV2 cells. Additionally, linderone activates the Nrf2/HO-1 pathway in both BV2 and HT22 cells. The strong effect of linderone can be attributed to these dual mechanisms. Our findings provide valuable evidence that linderone can be a potential therapeutic target for neurodegenerative diseases.

Author Contributions

Conceptualization, H.-K.L. and D.-S.L.; validation, Z.L., C.-S.Y. and H.L.; formal analysis, C.-S.Y. and H.L.; investigation, Z.L., C.-S.Y. and H.L.; resources, H.-K.L.; data curation, Z.L., C.-S.Y. and H.L.; writing—original draft preparation, Z.L. and D.-S.L.; writing—review and editing, Z.L. and D.-S.L.; visualization, Z.L., C.-S.Y. and H.L.; supervision, H.-K.L. and D.-S.L.; project administration, D.-S.L.; funding acquisition, D.-S.L. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by a research fund (team research project) from Chosun University (2020).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data supporting the findings of this study are available upon request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Moussa, C.; Hebron, M.; Huang, X.; Ahn, J.; Rissman, R.A.; Aisen, P.S. Turner RS. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease. J. Neuroinflam. 2017, 14, 1. [Google Scholar] [CrossRef] [PubMed]
  2. Kwon, H.S.; Koh, S.H. Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes. Transl. Neurodegener. 2020, 9, 42. [Google Scholar] [CrossRef] [PubMed]
  3. Rutsch, A.; Kantsjö, J.B.; Ronchi, F. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology. Front. Immunol. 2020, 11, 604179. [Google Scholar] [CrossRef] [PubMed]
  4. Nayak, D.; Roth, T.L.; McGavern, D.B. Microglia development and function. Annu. Rev. Immunol. 2014, 32, 367–402. [Google Scholar] [CrossRef]
  5. Amor, S.; McNamara, N.B.; Gerrits, E.; Marzin, M.C.; Kooistra, S.M.; Miron, V.E.; Nutma, E. White matter microglia heterogeneity in the CNS. Acta Neuropathol. 2022, 143, 125–141. [Google Scholar] [CrossRef]
  6. Borst, K.; Dumas, A.A.; Prinz, M. Microglia: Immune and non-immune functions. Immunity 2021, 54, 2194–2208. [Google Scholar] [CrossRef]
  7. Zusso, M.; Lunardi, V.; Franceschini, D.; Pagetta, A.; Lo, R.; Stifani, S.; Frigo, A.C.; Giusti, P.; Moro, S. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway. J. Neuroinflam. 2019, 16, 148. [Google Scholar] [CrossRef]
  8. Park, J.; Min, J.S.; Kim, B.; Chae, U.B.; Yun, J.W.; Choi, M.S.; Kong, I.K.; Chang, K.T.; Lee, D.S. Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-κB pathways. Neurosci. Lett. 2015, 584, 191–196. [Google Scholar] [CrossRef]
  9. Cui, Y.; Zhang, Z.; Zhou, X.; Zhao, Z.; Zhao, R.; Xu, X.; Kong, X.; Ren, J.; Yao, X.; Wen, Q.; et al. Microglia and macrophage exhibit attenuated inflammatory response and ferroptosis resistance after RSL3 stimulation via increasing Nrf2 expression. J. Neuroinflam. 2021, 18, 249. [Google Scholar] [CrossRef]
  10. Lawrence, T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 2009, 1, a001651. [Google Scholar] [CrossRef]
  11. Korbecki, J.; Bobiński, R.; Dutka, M. Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors. Inflamm. Res. 2019, 68, 443–458. [Google Scholar] [CrossRef] [PubMed]
  12. Shen, J.; Cheng, J.; Zhu, S.; Zhao, J.; Ye, Q.; Xu, Y.; Dong, H.; Zheng, X. Regulating effect of baicalin on IKK/IKB/NF-kB signaling pathway and apoptosis-related proteins in rats with ulcerative colitis. Int. Immunopharmacol. 2019, 73, 193–200. [Google Scholar] [CrossRef] [PubMed]
  13. Zhang, J.; Zheng, Y.; Luo, Y.; Du, Y.; Zhang, X.; Fu, J. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/TLR4/NF-κB pathways in BV2 cells. Mol. Immunol. 2019, 116, 29–37. [Google Scholar] [CrossRef] [PubMed]
  14. Lee, H.; Liu, Z.; Yoon, C.; Dong, L.; Ko, W.; Woo, E.; Lee, D. Anti-Neuroinflammatory and Anti-Inflammatory Activities of Phenylheptatriyne Isolated from the Flowers of Coreopsis lanceolata L. via NF-κB Inhibition and HO-1 Expression in BV2 and RAW264.7 Cells. Int. J. Mol. Sci. 2021, 22, 7482. [Google Scholar] [CrossRef] [PubMed]
  15. Wen, L.; Sun, W.; Xia, D.; Wang, Y.; Li, J.; Yang, S. The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-κB pathway. NeuroReport 2022, 33, 243–251. [Google Scholar] [CrossRef] [PubMed]
  16. Kaur, G.; Singh, N.K. The Role of Inflammation in Retinal Neurodegeneration and Degenerative Diseases. Int. J. Mol. Sci. 2021, 23, 386. [Google Scholar] [CrossRef]
  17. Kurtishi, A.; Rosen, B.; Patil, K.S.; Alves, G.W.; Møller, S.G. Cellular Proteostasis in Neurodegeneration. Mol. Neurobiol. 2019, 56, 3676–3689. [Google Scholar] [CrossRef] [PubMed]
  18. Yan, M.H.; Wang, X.; Zhu, X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol. Med. 2013, 62, 90–101. [Google Scholar] [CrossRef]
  19. Li, R.; Jia, Z.; Trush, M.A. Defining ROS in Biology and Medicine. React. Oxyg. Species 2016, 1, 9–21. [Google Scholar] [CrossRef]
  20. Rochette, L.; Lorin, J.; Zeller, M.; Guilland, J.C.; Lorgis, L.; Cottin, Y.; Vergely, C. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets? Pharmacol. Ther. 2013, 140, 239–257. [Google Scholar] [CrossRef]
  21. Ma, Q. Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 2013, 53, 401–426. [Google Scholar] [CrossRef] [PubMed]
  22. Loboda, A.; Jozkowicz, A.; Dulak, J. HO-1/CO system in tumor growth, angiogenesis and metabolism—Targeting HO-1 as an anti-tumor therapy. Vascul. Pharmacol. 2015, 74, 11–22. [Google Scholar] [CrossRef] [PubMed]
  23. Lee, H.; Liu, Z.; Dong, L.; Cheong, S.; Lee, D. Lycopus maackianus Makino MeOH Extract Exhibits Antioxidant and Anti-Neuroinflammatory Effects in Neuronal Cells and Zebrafish Model. Antioxidants 2022, 11, 690. [Google Scholar] [CrossRef] [PubMed]
  24. Ko, W.; Lee, H.; Kim, N.; Jo, H.; Woo, E.; Lee, K.; Han, Y.; Park, S.; Ahn, G.; Cheong, S.; et al. The Anti-Oxidative and Anti-Neuroinflammatory Effects of Sargassum horneri by Heme Oxygenase-1 Induction in BV2 and HT22 Cells. Antioxidants 2021, 10, 859. [Google Scholar] [CrossRef] [PubMed]
  25. Kim, J.A.; Jung, Y.S.; Kim, M.Y.; Yang, S.Y.; Lee, S.; Kim, Y.H. Protective effect of components isolated from Lindera erythrocarpa against oxidative stress-induced apoptosis of H9c2 cardiomyocytes. Phytother. Res. 2011, 25, 1612–1617. [Google Scholar] [CrossRef] [PubMed]
  26. Yoon, C.S.; Lee, H.; Liu, Z.; Lee, H.K.; Lee, D.S. Effects of Compounds Isolated from Lindera erythrocarpa on Anti-Inflammatory and Anti-Neuroinflammatory Action in BV2 Microglia and RAW264.7 Macrophage. Int. J. Mol. Sci. 2022, 23, 7122. [Google Scholar] [CrossRef]
  27. Hosseinzadeh, M.; Hadi, A.H.; Mohamad, J.; Khalilzadeh, M.A.; Cheahd, S.C.; Fadaeinasab, M. Flavonoids and linderone from Lindera oxyphylla and their bioactivities. Comb. Chem. High Throughput Screen 2013, 16, 160–166. [Google Scholar] [PubMed]
  28. Wang, S.Y.; Lan, X.Y.; Xiao, J.H.; Yang, J.C.; Kao, Y.T.; Chang, S.T. Antiinflammatory activity of Lindera erythrocarpa fruits. Phytother. Res. 2008, 22, 213–216. [Google Scholar] [CrossRef]
  29. Wang, T.; Ko, W.; Shin, J.Y.; Choi, D.; Lee, D.S.; Kim, S. Comparison of anti-inflammatory effects of Mecasin and its constituents on lipopolysaccharide-stimulated BV2 cells. Exp. Ther. Med. 2021, 21, 591. [Google Scholar] [CrossRef]
  30. Velagapudi, R.; Aderogba, M.; Olajide, O.A. Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-κB/p38-mediated neuroinflammation in activated BV2 microglia. Biochim. Biophys. Acta. 2014, 1840, 3311–3319. [Google Scholar] [CrossRef]
  31. Wang, L.; Zhao, D.; Wang, H.; Wang, L.; Liu, X.; Zhang, H. FPS-ZM1 inhibits LPS-induced microglial inflammation by suppressing JAK/STAT signaling pathway. Int. Immunopharmacol. 2021, 100, 108117. [Google Scholar] [CrossRef] [PubMed]
  32. Alhadidi, Q.; Shah, Z.A. Cofilin Mediates LPS-Induced Microglial Cell Activation and Associated Neurotoxicity through Activation of NF-κB and JAK-STAT Pathway. Mol. Neurobiol. 2018, 55, 1676–1691. [Google Scholar] [CrossRef] [PubMed]
  33. Subedi, L.; Lee, J.H.; Yumnam, S.; Ji, E.; Kim, S.Y. Anti-Inflammatory Effect of Sulforaphane on LPS-Activated Microglia Potentially through JNK/AP-1/NF-κB Inhibition and Nrf2/HO-1 Activation. Cells 2019, 8, 194. [Google Scholar] [CrossRef] [PubMed]
  34. Chamorro, Á.; Dirnagl, U.; Urra, X.; Planas, A.M. Neuroprotection in acute stroke: Targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol. 2016, 15, 869–881. [Google Scholar] [CrossRef]
  35. Verma, M.; Lizama, B.N.; Chu, C.T. Excitotoxicity, calcium and mitochondria: A triad in synaptic neurodegeneration. Transl. Neurodegener. 2022, 11, 3. [Google Scholar] [CrossRef] [PubMed]
  36. Kim, S.R.; Seong, K.J.; Kim, W.J.; Jung, J.Y. Epigallocatechin Gallate Protects against Hypoxia-Induced Inflammation in Microglia via NF-κB Suppression and Nrf-2/HO-1 Activation. Int. J. Mol. Sci. 2022, 23, 4004. [Google Scholar] [CrossRef]
  37. Wiklund, L.; Sharma, A.; Patnaik, R.; Muresanu, D.F.; Sahib, S.; Tian, Z.R.; Castellani, R.J.; Nozari, A.; Lafuente, J.V.; Sharma, H.S. Upregulation of hemeoxygenase enzymes HO-1 and HO-2 following ischemia-reperfusion injury in connection with experimental cardiac arrest and cardiopulmonary resuscitation: Neuroprotective effects of methylene blue. Prog. Brain Res. 2021, 265, 317–375. [Google Scholar] [CrossRef]
  38. Song, X.; Long, D. Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases. Front. Neurosci. 2020, 14, 267. [Google Scholar] [CrossRef]
Ijms 24 07569 g001 550
Figure 1. Linderone chemical structure (A) and effects on cell viability. BV2 (B) and HT22 (C) cells were incubated with various concentrations for 24 h. The MTT assay was used to determine cell viability.
Figure 1. Linderone chemical structure (A) and effects on cell viability. BV2 (B) and HT22 (C) cells were incubated with various concentrations for 24 h. The MTT assay was used to determine cell viability.
Ijms 24 07569 g001
Ijms 24 07569 g002 550
Figure 2. Effects of linderone on nitrite (A), PGE2 (B), TNF-α (C), and IL-6 (D) levels in LPS-induced BV2 cells. Cells were pretreated with linderone for 2 h and cultured for 24 h with LPS. * p < 0.05, *** p < 0.001 compared with LPS-treated group. Sulfuretin at a concentration of 20 μM was the positive control.
Figure 2. Effects of linderone on nitrite (A), PGE2 (B), TNF-α (C), and IL-6 (D) levels in LPS-induced BV2 cells. Cells were pretreated with linderone for 2 h and cultured for 24 h with LPS. * p < 0.05, *** p < 0.001 compared with LPS-treated group. Sulfuretin at a concentration of 20 μM was the positive control.
Ijms 24 07569 g002
Ijms 24 07569 g003 550
Figure 3. Expression of iNOS and COX-2 (A,B) in BV2 cells. Cells were pretreated for 2 h with linderone and cultured for 24 h with LPS. Band intensities were normalized to β-actin. * p < 0.05, ** p < 0.01 compared with LPS-treated group.
Figure 3. Expression of iNOS and COX-2 (A,B) in BV2 cells. Cells were pretreated for 2 h with linderone and cultured for 24 h with LPS. Band intensities were normalized to β-actin. * p < 0.05, ** p < 0.01 compared with LPS-treated group.
Ijms 24 07569 g003
Ijms 24 07569 g004 550
Figure 4. Effects of linderone on NF-κB (A,B) and p65 localization (C) in BV2 cells. Cells were pretreated with linderone for 2 h and cultured with LPS for 1 h. * p < 0.05, *** p < 0.001 compared with LPS-treated group.
Figure 4. Effects of linderone on NF-κB (A,B) and p65 localization (C) in BV2 cells. Cells were pretreated with linderone for 2 h and cultured with LPS for 1 h. * p < 0.05, *** p < 0.001 compared with LPS-treated group.
Ijms 24 07569 g004
Ijms 24 07569 g005 550
Figure 5. Neuroprotective effect of linderone on HT22 cells. After pretreated with linderone for 2 h, cell viability (A) was analyzed in the absence or presence of glutamate for 24 h; ROS generation (B) was detected using fluorescence microscope (original magnification: ×100); and fluorescence intensities were quantified using ImageJ software (C) * p < 0.05, ** p < 0.01, *** p < 0.001 compared with control group. N-acetyl-cysteine (NAC, 1 mM) was the positive control.
Figure 5. Neuroprotective effect of linderone on HT22 cells. After pretreated with linderone for 2 h, cell viability (A) was analyzed in the absence or presence of glutamate for 24 h; ROS generation (B) was detected using fluorescence microscope (original magnification: ×100); and fluorescence intensities were quantified using ImageJ software (C) * p < 0.05, ** p < 0.01, *** p < 0.001 compared with control group. N-acetyl-cysteine (NAC, 1 mM) was the positive control.
Ijms 24 07569 g005
Ijms 24 07569 g006 550
Figure 6. Effects of linderone on HO-1 expression in BV2 (A) and HT22 cells (B). Cells were treated with linderone or CoPP for 12 h. * p < 0.05, *** p < 0.001 compared with control group.
Figure 6. Effects of linderone on HO-1 expression in BV2 (A) and HT22 cells (B). Cells were treated with linderone or CoPP for 12 h. * p < 0.05, *** p < 0.001 compared with control group.
Ijms 24 07569 g006
Ijms 24 07569 g007 550
Figure 7. Effects of linderone on Nrf2 in BV2 (A) and HT22 cells (B). Cells were treated with linderone at different time points. * p < 0.05 compared with control group.
Figure 7. Effects of linderone on Nrf2 in BV2 (A) and HT22 cells (B). Cells were treated with linderone at different time points. * p < 0.05 compared with control group.
Ijms 24 07569 g007
Ijms 24 07569 g008 550
Figure 8. Inhibitory effects of linderone on nitrite production through regulating HO-1 activity in BV2 (A) and HT22 cells (B). Cells were pretreated with SnPP or linderone and then stimulated for 24 h with LPS or glutamate. *** p < 0.001 vs. LPS group. ## p < 0.01 vs. LPS and linderone group. † p < 0.05 compared with glutamate group. § p < 0.05 vs. glutamate and linderone group.
Figure 8. Inhibitory effects of linderone on nitrite production through regulating HO-1 activity in BV2 (A) and HT22 cells (B). Cells were pretreated with SnPP or linderone and then stimulated for 24 h with LPS or glutamate. *** p < 0.001 vs. LPS group. ## p < 0.01 vs. LPS and linderone group. † p < 0.05 compared with glutamate group. § p < 0.05 vs. glutamate and linderone group.
Ijms 24 07569 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Liu, Z.; Yoon, C.-S.; Lee, H.; Lee, H.-K.; Lee, D.-S. Linderone Isolated from Lindera erythrocarpa Exerts Antioxidant and Anti-Neuroinflammatory Effects via NF-κB and Nrf2 Pathways in BV2 and HT22 Cells. Int. J. Mol. Sci. 2023, 24, 7569. https://doi.org/10.3390/ijms24087569

AMA Style

Liu Z, Yoon C-S, Lee H, Lee H-K, Lee D-S. Linderone Isolated from Lindera erythrocarpa Exerts Antioxidant and Anti-Neuroinflammatory Effects via NF-κB and Nrf2 Pathways in BV2 and HT22 Cells. International Journal of Molecular Sciences. 2023; 24(8):7569. https://doi.org/10.3390/ijms24087569

Chicago/Turabian Style

Liu, Zhiming, Chi-Su Yoon, Hwan Lee, Hyeong-Kyu Lee, and Dong-Sung Lee. 2023. "Linderone Isolated from Lindera erythrocarpa Exerts Antioxidant and Anti-Neuroinflammatory Effects via NF-κB and Nrf2 Pathways in BV2 and HT22 Cells" International Journal of Molecular Sciences 24, no. 8: 7569. https://doi.org/10.3390/ijms24087569

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop